MelBrainSys

Publikationen

2023

Hausmann, D., D. C. Hoffmann, V. Venkataramani, E. Jung, S. Horschitz, S. K. Tetzlaff, A. Jabali, L. Hai, T. Kessler, D. D. Azoŕin, S. Weil, A. Kourtesakis, P. Sievers, A. Habel, M. O. Breckwoldt, M. A. Karreman, M. Ratliff, J. M. Messmer, Y. Yang, E. Reyhan, S. Wendler, C. Löb, C. Mayer, K. Figarella, M. Osswald, G. Solecki, F. Sahm, O. Garaschuk, T. Kuner, P. Koch, M. Schlesner, W. Wick and F. Winkler (2023). "Autonomous rhythmic activity in glioma networks drives brain tumour growth." Nature 613: 179–186. MelBrainSys doi.org/10.1038/s41586-022-05520-4.

Karreman, M. A., A. T. Bauer, G. Solecki, A. S. Berghoff, C. D. Mayer, K. Frey, N. Hebach, M. J. Feinauer, N. L. Schieber, C. Tehranian, L. Mercier, M. Singhal, V. Venkataramani, M. C. Schubert, D. Hinze, M. Hölzel, I. Helfrich, D. Schadendorf, S. W. Schneider, D. Westphal, H. G. Augustin, J. G. Goetz, Y. Schwab, W. Wick and F. Winkler (2023). "Active remodeling of capillary endothelium via cancer cell-derived MMP9 promotes metastatic brain colonization." Cancer Res. MelBrainSys doi.org/10.1158/0008-5472.CAN-22-3964.

Kraft, T., K. Grützmann, M. Meinhardt, F. Meier, D. Westphal and M. Seifert (2023). "Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases." Sci Rep 13(444): 1–18. MelBrainSys doi.org/10.1038/s41598-022-24940-w.

2022

Messmer, J. M., M. Piechutta, V. Venkataramani, C. Mayer, A. S. Berghoff, D. Hinze, M. Hölzel, I. Helfrich, D. Schadendorf, W. Wick, M. A. Karreman and F. Winkler (2022). "Abstract 2487: Distinct venous brain vessels provide structures for T lymphocyte recruitment to brain tumors in mouse models of intracranial melanoma." Cancer Res 82(12_Supplement): 2487. MelBrainSys doi.org/10.1158/1538-7445.AM2022-2487.

Schulz, A., J. Raetz, P. C. Karitzky, L. Dinter, J. K. Tietze, I. Kolbe, T. Käubler, B. Renner, S. Beissert, F. Meier and D. Westphal (2022). "Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma." Cancers 14(19): 4930. MelBrainSys doi.org/10.3390/cancers14194930.

Tehranian, C., L. Fankhauser, P. Harter, C. Ratcliffe, P. Zeiner, J. Messmer, D. Hoffmann, K. Frey, D. Westphal, M. Ronellenfitsch, E. Sahai, W. Wick, M. A. Karreman and F. Winkler (2022). "The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis." Neuro Oncol 24(2): 213–225. MelBrainSys doi.org/10.1093/neuonc/noab159.

2021

Bosch, C., M. A. Karreman, A. Pacureanu, A. T. Schaefer and A. Walter (2021). Correlative multimodality imaging across scales. Imaging Modalities for Biological and Preclinical Research: A Compendium, Volume 2 IOP Publishing: III.3–1--III.3-12.

Karreman, M. A. (2021). Intravital microscopy. Imaging Modalities for Biological and Preclinical Research: A Compendium, Volume 2 IOP Publishing. 2: II.1–1--II.1-11.

Steininger, J., F. F. Gellrich, A. Schulz, D. Westphal, S. Beissert and F. Meier (2021). "Systemic Therapy of Metastatic Melanoma: On the Road to Cure." Cancers 13(6): 1430. MelBrainSys doi.org/10.3390/cancers13061430.

Tehranian, C., L. Fankhauser, P. N. Harter, C. D. H. Ratcliffe, P. S. Zeiner, J. M. Messmer, D. C. Hoffmann, K. Frey, D. Westphal, M. W. Ronellenfitsch, E. Sahai, W. Wick, M. A. Karreman and F. Winkler (2021). "BSCI-11. Targeting PI3K/Akt/mTOR pathway to prevent melanoma brain metastasis." Neurooncology Advances 3(Suppl 3): iii3. MelBrainSys doi.org/10.1093/noajnl/vdab071.010.

Venkataramani, V., M. A. Karreman and F. Winkler (2021). "Neuroscience meets cancer: networks and neuronal input to brain tumors." Neuroforum 27(4): 225–231. MelBrainSys doi.org/10.1515/nf-2021-0020.

2020

Karreman, M. A. and F. Winkler (2020). "Targeting an adhesion molecule to prevent brain colonization of lung cancer." Neuro-Oncology 22(7): 899. MelBrainSys doi.org/10.1093/neuonc/noaa099.

Diese Seite nutzt Website Tracking-Technologien von Dritten, um ihre Dienste anzubieten. Ich bin damit einverstanden und kann meine Einwilligung jederzeit mit Wirkung für die Zukunft widerrufen oder ändern.

Einstellungen Akzeptieren ImpressumDatenschutz